$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
News
News
Medical Halo Global Pharmaceutical News_Targeted Drugs_New Anti-Cancer Drugs_Overseas Medical Information_【Medical Halo Global Pharmaceutical】
Detailed explanation of the role and efficacy of mobosetinib/mobosetinib
2026-02-01 22:25:32
Check Details
Tepotinib plus osimertinib shows activity in EGFR+ non-small cell lung cancer
2026-02-01 22:25:32
Check Details
What are the detailed instructions for regorafenib?
2026-02-01 22:25:32
Check Details
What are the medical insurance reimbursement conditions for pazopanib/pazopanib?
2026-02-01 22:25:32
Check Details
Professional analysis: The therapeutic effect of Opicapone is revealed!
2026-02-01 22:25:32
Check Details
Should fenelidone be taken before or after meals?
2026-02-01 22:25:32
Check Details
Why is rasagiline recommended to be taken in small amounts?
2026-02-01 22:25:32
Check Details
What is the main function of pimetibi
2026-02-01 22:25:32
Check Details
FDA approves Gomekli (mirdametinib) for adult and pediatric patients with neurofibromatosis type 1
2026-02-01 22:25:32
Check Details
What disease does Gomekli (mirdametinib) treat?
2026-02-01 22:25:32
Check Details
Gomekli (mirdametinib) drug introduction
2026-02-01 22:25:32
Check Details
Dosage and usage of Gomekli (mirdametinib)
2026-02-01 22:25:32
Check Details
1
2
...
1345
1346
1347
1348
1349
1350
1351
...
10225
10226
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
Pemigatinib vs. Anlotinib: Key Differences Between FGFR-Targeted Therapy and Multi-Target Anti-Angiogenic Treatment
2
Enasidenib (IDHIFA): A Comprehensive Guide to Targeted Therapy for IDH2-Mutated Acute Myeloid Leukemia
3
Midostaurin vs. Gilteritinib: Key Differences in FLT3-Targeted AML Therapy
4
Lapatinib: A Targeted Anticancer Agent — Not Merely Symptom Relief
5
Filgotinib: Mechanism of Action and Clinical Applications Explained
6
Lapatinib: Proper Administration Guide and Key Precautions
7
Capivasertib (Truqap) Complete Medication Guide: Indications, Dosing, Safety, and Precautions
8
Cemiplimab Storage and Handling Guide
9
ASCO 2026: Spevatamig Opens a New Path in Pancreatic Cancer Immunotherapy
10
FDA Approves First mRNA Flu Vaccine mFLUSIVA
11
Nintedanib Indications Explained: Beyond Idiopathic Pulmonary Fibrosis
12
How Long Does Belumosudil Take to Work for Pulmonary cGVHD?